This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Conn Syndrome
Information about Conn Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Conn Syndrome
Most recent studies have shown that Conn Syndrome shares some biological mechanisms with adenoma, adrenal-cortical-adenoma, adrenal-gland-diseases, adrenal-gland-neoplasms, adrenal-hyperplasia, carcinoma, cushing-syndrome, essential-hypertension, hyperaldosteronism, hyperplasia, hypertension-renovascular, hypertensive-disease, kidney-diseases, malignant-neoplasm-of-adrenal-cortex, malignant-paraganglionic-neoplasm, neoplasms, pheochromocytoma, renal-vascular-disorder, secondary-hypertension, tumors-of-adrenal-cortex.
Among the many pathways, these few ones have gauged particular interests from scientists studying Conn Syndrome, and have been seen in publications frequently: Aldosterone Secretion, Cell Growth, Cell Proliferation, Circadian Rhythm, Cortisol Secretion, Diuresis, Enucleation, Excretion, Glomerular Filtration, Hemostasis, Hormone Secretion, Insulin Secretion, Localization, Natriuresis, Pathogenesis, Regulation Of Aldosterone Secretion, Secretion, Transport, Vasoconstriction, Vasodilation
Quite a number of genes have been found to play important roles in Conn Syndrome, such as ACE, AGT, AMY2A, BLOC1S6, CAT, CYP11B1, CYP11B2, ENPEP, EPB42, INS, KCNJ5, KLK4, NPPA, NR3C2, POMC, PRH1, REN, S100A6. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.